SARS-CoV-2感染与呼吸机相关性下呼吸道感染发生率的关系:一项欧洲多中心队列研究
该欧洲36个ICU多中心回顾性队列纳入1576例有创机械通气>48h的成人患者,分为SARS-CoV-2肺炎组(568例)、流感肺炎组(482例)和无病毒感染组(526例)。VA-LRTI(含VAT和VAP)经临床、影像和定量微生物标准诊断,前瞻性识别。SARS-CoV-2组VA-LRTI累积发生率50.5%,显著高于流感组30.3%(调整sHR 1.60,95%CI 1.26-2.04)和无病毒感染组25.3%(调整sHR 1.7,95%CI 1.2-2.39)。革兰阴性杆菌占VA-LRTI的82%-89.7%,以铜绿假单胞菌、肠杆菌属和克雷伯菌属为主。
要点
- SARS-CoV-2肺炎机械通气患者VA-LRTI发生率50.5%,显著高于流感肺炎30.3%(调整sHR 1.60,95%CI 1.26-2.04)。
- SARS-CoV-2组VA-LRTI发生率亦显著高于无病毒感染组25.3%(调整sHR 1.7,95%CI 1.2-2.39)。
- 革兰阴性杆菌占VA-LRTI的82%-89.7%,主要为铜绿假单胞菌、肠杆菌属和克雷伯菌属。
- 研究为回顾性队列,作者指出残余混杂可能仍影响效应估计,需谨慎解读。
- VA-LRTI诊断采用临床、影像和定量微生物标准,胸片由至少两名医生分析。
适用人群与场景
- 36个欧洲ICU的成人患者,接受有创机械通气>48h,且ICU入科时存在SARS-CoV-2肺炎、流感肺炎或无病毒感染。
诊断标准与关键阈值
- VA-LRTI包括呼吸机相关性气管支气管炎(VAT)和呼吸机相关性肺炎(VAP),采用临床、影像和定量微生物标准诊断。
- 胸片由至少两名医生分析。
处置流程与药物剂量
- 原文未提及
红旗征与不能漏的情况
- 原文未提及
研究设计与关键结果
- 研究类型:欧洲多中心回顾性队列,36个ICU,纳入1576例成人有创机械通气>48h患者。
- 分组:SARS-CoV-2肺炎组568例,流感肺炎组482例,无病毒感染组526例。
- 主要终点:VA-LRTI累积发生率SARS-CoV-2组50.5%(287例),流感组30.3%(146例,调整sHR 1.60,95%CI 1.26-2.04),无病毒感染组25.3%(133例,调整sHR 1.7,95%CI 1.2-2.39)。
- 微生物学:革兰阴性杆菌占VA-LRTI的82%-89.7%,主要为铜绿假单胞菌、肠杆菌属和克雷伯菌属。
- 原文未提及关键次要终点和不良事件的具体结果。
证据类型、等级与局限
- 证据类型:多中心回顾性队列研究。
- 局限:回顾性设计,作者指出残余混杂可能仍影响效应估计。
对床旁实践的改变
- 对于SARS-CoV-2肺炎接受有创机械通气>48h的成人患者,应警惕VA-LRTI发生风险高于流感肺炎或无病毒感染患者。
- VA-LRTI以革兰阴性杆菌为主,经验性抗感染方案需覆盖铜绿假单胞菌、肠杆菌属和克雷伯菌属。
- 原文未提及具体抗菌药物剂量或疗程推荐。
指南或共识出处
- Intensive Care Med:Relationship between SARS-CoV-2 infection and the incidence of ventilator-associated lower respiratory tract infections: a European multicenter cohort study.
以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。
英文原文(摘要)· 点击展开
PURPOSE: Although patients with SARS-CoV-2 infection have several risk factors for ventilator-associated lower respiratory tract infections (VA-LRTI), the reported incidence of hospital-acquired infections is low. We aimed to determine the relationship between SARS-CoV-2 pneumonia, as compared to influenza pneumonia or no viral infection, and the incidence of VA-LRTI.
METHODS: Multicenter retrospective European cohort performed in 36 ICUs. All adult patients receiving invasive mechanical ventilation > 48 h were eligible if they had: SARS-CoV-2 pneumonia, influenza pneumonia, or no viral infection at ICU admission. VA-LRTI, including ventilator-associated tracheobronchitis (VAT) and ventilator-associated pneumonia (VAP), were diagnosed using clinical, radiological and quantitative microbiological criteria. All VA-LRTI were prospectively identified, and chest-X rays were analyzed by at least two physicians. Cumulative incidence of first episodes of VA-LRTI was estimated using the Kalbfleisch and Prentice method, and compared using Fine-and Gray models.
RESULTS: 1576 patients were included (568 in SARS-CoV-2, 482 in influenza, and 526 in no viral infection groups). VA-LRTI incidence was significantly higher in SARS-CoV-2 patients (287, 50.5%), as compared to influenza patients (146, 30.3%, adjusted sub hazard ratio (sHR) 1.60 (95% confidence interval (CI) 1.26 to 2.04)) or patients with no viral infection (133, 25.3%, adjusted sHR 1.7 (95% CI 1.2 to 2.39)). Gram-negative bacilli were responsible for a large proportion (82% to 89.7%) of VA-LRTI, mainly Pseudomonas aeruginosa, Enterobacter spp., and Klebsiella spp.
CONCLUSIONS: The incidence of VA-LRTI is significantly higher in patients with SARS-CoV-2 infection, as compared to patients with influenza pneumonia, or no viral infection after statistical adjustment, but residual confounding may still play a role in the effect estimates.
参考来源
- Rouzé A, Martin-Loeches I, Povoa P, et al. Relationship between SARS-CoV-2 infection and the incidence of ventilator-associated lower respiratory tract infections: a European multicenter cohort study. Intensive Care Med. 2021. PMID: 33388794. doi:10.1007/s00134-020-06323-9
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。